Practical considerations on the use of TPO-RAs in ITP

Dr Vickie McDonald is a consultant haematologist at the Royal London Hospital, London, UK. Her main interests are disorders of coagulation, including ITP. She looks after patients with inherited and acquired disorders of clotting and platelets and runs specialist clinics in ITP. She is an honorary senior lecturer at Queen Mary University of London and is the national chief investigator for the UK ITP registry in addition to the PI and CI for several trials in ITP, both early and late phase studies.

Dr Hillary Maitland is an Associate Professor of Medicine in the division of Hematology Oncology at the University of Virginia Emily Couric Clinical Cancer Center in Charlottesville Virginia. Her clinical focus is in the treatment of patients with non-malignant hematologic conditions, particularly those with disorders of hemostasis. She leads the hospital’s quality coalition for anticoagulation and thrombosis prevention. Her research focus is on quality and safety of anticoagulant therapies, treatment and prevention of thrombosis.